Repare Therapeutics Inc. (RPTX) Social Stream



Repare Therapeutics Inc. (RPTX): $26.35

0.22 (+0.84%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Repare Therapeutics Inc (RPTX) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Repare Therapeutics Inc.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
8 $54 $40 $46.875 $27.07 73.16%
8 $54 $40 $46.75 $27.07 72.7%

The Trend in the Analyst Price Target


Over the past 13 months, RPTX's average price target has gone up $9.95.

Over the past 13 months, RPTX's average upside potential has been 34.19%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-11-11 8 54 40 46.75 26.78 74.57%
2021-05-08 1 51 40 46.50 33.07 40.61%
2020-10-26 5 42 27 36.80 NA NA%

RPTX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.06 7 1 0 0 0 8

The Trend in the Broker Recommendations


RPTX's average broker recommendation rating improved by 1.02 over the prior 153 days.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for RPTX as an investment opportunity.

  • RPTX has a greater upside potential (average analyst target price relative to current price) than 156.28% of all US stocks.
  • The number of analysts covering the stock of RPTX is higher than 190.26% of stocks in the small market cap category.
  • RPTX has a higher average analyst price target than 170.83% of stocks in the small market cap category.
  • RPTX has a lower variance in analysts' estimates than 31.62% of Pharmaceutical Products stocks.

Stocks similar to Repare Therapeutics Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are BBIO, OCDX and INSM.

Is RPTX a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5824 seconds.